Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer
Recent studies have proposed that pyruvate dehydrogenase E1 component subunit alpha (PDHA1), a cuproptosis-key gene, is crucial to the glucose metabolism reprogram of tumor cells. However, the functional roles and regulated mechanisms of PDHA1 in multiple cancers are largely unknown. The Cancer Geno...
Saved in:
Main Authors: | Langmei Deng (Author), Anqi Jiang (Author), Hanqing Zeng (Author), Xiaoji Peng (Author), Liying Song (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020) -
Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients
by: Jiangang Sun, et al.
Published: (2024) -
Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
by: He Zhang, et al.
Published: (2023) -
Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
by: Yueming Zhang, et al.
Published: (2021) -
The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer
by: Yin He, et al.
Published: (2024)